Incidence and treatment of dysgeusia in patients with glossodynia.
In 96 patients who visited our hospital with glossodynia, we conducted gustatory tests, measured serum zinc and copper levels, examined lingual papillae using biomicroscopy, conducted psychological tests and investigated the effectiveness of treatments directed at the cause of dysgeusia. Gustatory test results showed that 43 (44.8%) of the patients had dysgeusia, which was mild in 62.8%, moderate in 30.2% and severe in 7.0%. By giving higher priority to treatment of dysgeusia than to glossodynia, pain disappeared or was relieved and gustatory sensation improved in 27 (62.8%) of these 43 patients. Overall, pain disappeared or was improved in 65 (67.7%) cases. When treating glossodynia, it is important to diagnose the cause of pain and to give higher priority to treating that cause. The clinical efficacy of treatment for glossodynia will be improved when the presence or absence of dysgeusia is diagnosed early in the course of treatment.
Department of Otolaryngology, Nihon University School of Medicine, Tokyo, Japan.
Masami
M
Tanaka
Hideto
H
Kitago
Susumu
S
Ogawa
Eikichi
E
Tokunaga
Minoru
M
Ikeda
Hiroshi
H
Tomita
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003300:Copper / Q000097:blood; D004408:Dysgeusia / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D005926:Glossalgia / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007501:Iron / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014805:Vitamin B 12 / Q000097:blood; D015032:Zinc / Q000097:blood
D003300:Copper; D007501:Iron; D015032:Zinc; D014805:Vitamin B 12